Taurus Large Cap Fund
Direct · GrowthAI Summary
Taurus Large Cap Fund has delivered a 3Y SIP XIRR of 13.02% and 5Y of 12.24%, trailing the category averages of 14.06% and 14.39% respectively. Against the NIFTY 50, the fund shows strong alpha over shorter windows (14.95% over 1Y, 8.48% over 3Y) but alpha fades to just 0.36% over 10Y, indicating benchmark-beating performance has been concentrated in recent periods. The 1Y XIRR of 9.51% does beat the category average of 7.92%.
The fund exhibits a defensive profile with beta below 1 across all windows (0.89-0.99) and downside capture consistently under 96%, meaning it falls less than the benchmark in declines. It has experienced 10 drawdown events exceeding 10%, with a maximum drawdown of -35.12% that took 233 days to recover. Calmar ratios of roughly 0.29-0.37 across horizons suggest modest risk-adjusted returns relative to the depth of its worst drawdowns.
The portfolio holds 37 stocks with the top 10 accounting for about 53% of NAV, led by Divi's Laboratories at 8.94% and HDFC Bank at 7.07%. Banks dominate sector exposure at 23.0%, followed by Pharmaceuticals at 9.9% and FMCG at 7.9%, giving the fund a financials-heavy tilt. Positions like Sigma Advanced Systems (5.56%) and Advit Jewels (5.39%) add some off-benchmark exposure beyond typical large cap mandates.
The fund lags category average SIP XIRR across most long horizons, trailing by roughly 1-2 percentage points at 3Y, 5Y, 7Y, 10Y, and 12Y. Calendar year returns show inconsistency, ranging from 38.6% in 2014 to -4.99% in 2018 and just 5.0% in 2025. Its high expense ratio of 2.32% is a likely headwind versus peers in the large cap category.
This fund suits investors seeking large cap exposure with below-benchmark downside volatility and a long horizon of 7-10 years or more. Its defensive capture ratios appeal to moderate risk tolerance investors who prioritize capital protection in corrections. However, investors should weigh the 2.32% expense ratio and persistent underperformance versus category peers before committing.
- Consistently low downside capture (81-95%) with beta below 1, indicating better-than-benchmark resilience in falling markets
- Strong recent alpha versus NIFTY 50, including 14.95% over 1Y and 8.48% over 3Y
- Diversified 37-stock portfolio with meaningful exposure to defensive sectors like FMCG and pharma alongside banks
- High expense ratio of 2.32% that erodes returns and likely contributes to category underperformance
- SIP XIRR trails category averages across all horizons from 3Y to 12Y, with alpha versus the benchmark nearly vanishing over 10Y and 15Y
- Severe historical drawdown of -35.12% with a lengthy 233-day recovery and 10 drawdown events exceeding 10%
Generated on 10-10-2026, 3:02 AM. Verify before investing.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.60 L | 13.8% | -55.7% | 71.7% |
| 3 Years | ₹36.00 L | ₹42.14 L | 11.0% | -22.0% | 28.4% |
| 5 Years | ₹60.00 L | ₹78.88 L | 10.8% | -10.6% | 23.2% |
| 7 Years | ₹84.00 L | ₹1.24 Cr | 11.0% | -4.0% | 18.5% |
| 10 Years | ₹1.20 Cr | ₹2.21 Cr | 11.6% | 7.6% | 14.9% |
| 12 Years | ₹1.44 Cr | ₹2.96 Cr | 11.4% | 9.4% | 13.4% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY 50 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 13.8% | 14.3% | 7.8% | -0.4% |
| 3 Years | 11.0% | 11.0% | 14.0% | +0.0% |
| 5 Years | 10.8% | 10.4% | 14.4% | +0.5% |
| 7 Years | 11.0% | 10.6% | 14.0% | +0.4% |
| 10 Years | 11.6% | 11.4% | 14.3% | +0.2% |
| 12 Years | 11.4% | 11.3% | 13.8% | +0.1% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 12.9% | 8.2% | -30.6% | 73.7% | 0.38 | 0.99 | 80% | — | — |
| 3 Years | 11.3% | 12.2% | -8.2% | 24.5% | 0.88 | 2.17 | 95% | — | — |
| 5 Years | 10.7% | 10.8% | -3.4% | 23.5% | 0.95 | 2.97 | 99% | — | — |
| 10 Years | 10.9% | 10.7% | 8.0% | 13.7% | 3.84 | — | 100% | — | — |
Calmar Ratio by Duration
Compared against NIFTY 50
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +13.24 | 0.89 | 100.3% | 81.4% | 3.8% | -11.4% |
| 3 Years | +7.74 | 0.97 | 101.9% | 92.3% | 13.0% | 5.3% |
| 5 Years | +4.98 | 0.99 | 101.0% | 95.0% | 9.4% | 4.4% |
| 7 Years | +2.49 | 0.93 | 95.5% | 92.6% | 12.4% | 10.2% |
| 10 Years | +0.23 | 0.94 | 94.9% | 94.3% | 10.2% | 10.2% |
| 12 Years | +1.08 | 0.94 | 95.4% | 93.8% | 10.2% | 9.3% |
| 15 Years | +0.43 | 0.95 | 96.0% | 95.2% | 9.6% | 9.3% |
| # | Stock | % of NAV |
|---|---|---|
| 1 | Divi's Laboratories Ltd. | 8.94% |
| 2 | HDFC Bank Ltd. | 7.07% |
| 3 | ITC Ltd. | 6.50% |
| 4 | ICICI Bank Ltd. | 6.43% |
| 5 | Sigma Advanced Systems Ltd. | 5.56% |
| 6 | Advit Jewels Ltd. | 5.39% |
| 7 | Bharti Airtel Ltd. | 3.89% |
| 8 | Reliance Industries Ltd. | 3.66% |
| 9 | State Bank of India | 3.48% |
| 10 | Varun Beverages Ltd. | 3.32% |